XOOMAR
Get a free API key

Emmaus Life Sciences (EMMA)

Emmaus Life Sciences on one page: short interest, fails to deliver, earnings dates and insider trades. Listed on OTC, classified by the SEC as pharmaceutical preparations.

Download CSV

3K

Short interest

settlement 2026-10-15

1.0

Days to cover

unchanged vs prior

4,583

Fails to deliver

settlement 2026-09-01

Fri 13 Nov

Next earnings

estimated date

$15K

Insider flow, 90 days

4 buys, 0 sells

As of 2026-10-15.

Short interest

FINRA, twice a month. The newest 48 settlements in the table, 48 in the chart. JSON

As of 15 October 2026, short interest in EMMA is 3,004 shares, down 13,173 shares over the last month. Over the last 48 readings it ranged from 670 shares (31 October 2024) to 127,805 shares (27 February 2026). The latest reading sits at the bottom of that range. At the reported average volume of 20K shares a day that is 1.0 days to cover.

Embed this chart.The embed keeps its attribution line.
<iframe src="https://xoomar.com/embed/stocks/emma" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>
PreviewDark previewAdd ?theme=dark to the src for a dark chart.
SettlementShares shortChangeAvg daily volumeDays to cover
2026-10-153,004-78.4%19,9591.00
2026-09-3013,919-14.0%104,5211.00
2026-09-1516,177-24.9%81,0121.00
2026-08-3121,539+610.1%885,6051.00
2026-08-143,033+0.0%115,5751.00
2026-07-313,033+0.0%26,3481.00
2026-07-153,033+85.7%65,5151.00
2026-06-301,633+0.0%110,9991.00
2026-06-151,633+0.0%139,7601.00
2026-05-291,633+0.0%83,4191.00
2026-05-151,633+0.0%138,1991.00
2026-04-301,633+0.0%50,7261.00
2026-04-151,633-98.7%172,4811.00
2026-03-31127,097-0.4%17,1547.41
2026-03-13127,555-0.2%6,25320.40
2026-02-27127,805+4.2%94,2961.36
2026-02-13122,716+7378.1%86,4341.42
2026-01-301,641+0.0%11,2951.00
2026-01-151,641-6.2%62,7791.00
2025-12-311,750+0.2%127,7021.00
2025-12-151,746+0.0%56,0991.00
2025-11-281,746-62.0%59,2091.00
2025-11-144,589+162.8%261,1031.00
2025-10-311,746+2.3%129,9551.00
2025-10-151,706-87.5%289,0271.00
2025-09-3013,681-44.9%32,6191.00
2025-09-1524,818+0.0%18,2991.36
2025-08-2924,819+16.6%137,4041.00
2025-08-1521,288-0.1%42,1701.00
2025-07-3121,313+13.3%1,13318.81
2025-07-1518,813+42.4%9,9401.89
2025-06-3013,213-60.2%91,7081.00
2025-06-1333,213+4857.2%3,6179.18
2025-05-30670+0.0%31,7661.00
2025-05-15670-51.4%37,7821.00
2025-04-301,379-75.4%4,0111.00
2025-04-155,614+16.5%8,3911.00
2025-03-314,819-25.0%22,7091.00
2025-03-146,424+31.4%43,8521.00
2025-02-284,889-51.7%145,4821.00
2025-02-1410,120-53.5%132,0181.00
2025-01-3121,748+48.0%20,3981.07
2025-01-1514,692+2092.8%24,6021.00
2024-12-31670-8.7%131,4271.00
2024-12-13734-21.9%112,7721.00
2024-11-29940-5.2%30,3141.00
2024-11-15991+47.9%46,6841.00
2024-10-31670+0.0%65,1841.00

Fails to deliver

SEC, the last 30 settlement dates with a fail. JSON

As of 1 September 2026, the fails-to-deliver balance in EMMA is 4,583 shares, down 1,800 shares over the last settlement date. Over the last 30 readings it ranged from 83 shares (30 May 2024) to 40,000 shares (24 August 2026).

SettlementShares failedPriceValue
2026-09-014,583$0.06$275
2026-08-316,383$0.08$511
2026-08-2440,000$0.03$1K
2024-07-033,151$0.09$284
2024-05-3083$0.09$7
2024-03-262,607$0.09$235
2024-03-07241$0.11$27
2024-03-064,641$0.10$464
2024-03-055,841$0.11$643
2024-03-044,129$0.13$537
2024-02-095,850$0.09$527
2024-02-086,424$0.11$707
2024-02-076,424$0.13$835
2024-01-311,178$0.12$141
2024-01-301,244$0.13$162
2024-01-292,294$0.10$229
2023-12-01740$0.13$96
2023-11-30789$0.13$103
2023-11-27500$0.12$60
2023-11-24756$0.10$76
2023-11-22789$0.09$71
2023-11-20972$0.12$117
2023-11-17972$0.11$107
2023-11-16872$0.11$96
2023-07-201,483$0.25$371
2023-07-191,483$0.24$356
2023-07-181,483$0.24$356
2023-07-171,483$0.24$356
2023-06-02439$0.25$110
2022-11-232,076$0.40$830

Insider trades

SEC Form 4, newest first. JSON

Insiders at EMMA reported 4 open-market buys worth $15K in the last 90 days and no open-market sells. Latest filing: LEE WILLIS C (CEO) on 2026-08-31.

DateInsiderTitleTypeSharesPriceValueOwned after
2026-08-31LEE WILLIS CCEOBuy100K$0.05$5K690K
2026-08-28LEE WILLIS CCEOBuy95K$0.06$6K590K
2026-08-27LEE WILLIS CCEOBuy50K$0.05$3K495K
2026-08-25LEE WILLIS CCEOBuy46K$0.04$2K445K
2025-08-29LEE WILLIS CCEOBuy170K$0.01$2K275K
2025-05-30LEE WILLIS CCEOBuy70K$0.02$1K229K
2024-09-16Lim Seah H.DirectorBuy20K$0.04$8004.6M
2024-02-29LEE WILLIS CCo-President & COOBuy77K$0.13$10K159K
2024-02-28LEE WILLIS CCo-President & COOBuy15K$0.12$2K82K
2024-02-27LEE WILLIS CCo-President & COOBuy10K$0.13$1K67K
2024-02-26LEE WILLIS CCo-President & COOBuy13K$0.12$2K57K
2023-12-20Lim Seah H.DirectorSell33K$0.05$2K4.6M
2023-12-15ZEN Wei PeuDirectorOther transaction3.8M$0.29$1.1M4.8M
2023-12-15Lim Seah H.DirectorSell6K$0.11$660172K
2023-12-15Lim Seah H.DirectorOther transaction4.4M$0.29$1.3M4.6M
2023-11-30LEE WILLIS CCOOBuy59K$0.12$7K395K
2023-11-30LEE WILLIS CCOOBuy7K$0.12$890395K
2023-11-29LEE WILLIS CCOOBuy36K$0.12$4K336K
2023-11-29LEE WILLIS CCOOBuy4K$0.12$519336K
2023-11-28LEE WILLIS CCOOBuy12K$0.12$1K300K
2023-11-28LEE WILLIS CCOOBuy1K$0.12$176300K
2023-11-14LEE WILLIS CCOOBuy1K$0.12$13244K
2023-11-14LEE WILLIS CCOOBuy132$0.12$1644K
2023-09-05Lim Seah H.DirectorBuy2K$0.15$255178K
2023-08-31LEE WILLIS CCOOBuy6K$0.15$90043K
2023-08-31LEE WILLIS CCOOBuy900$0.15$13543K
2023-08-30Lim Seah H.DirectorBuy20K$0.15$3K176K
2023-08-25LEE WILLIS CCOOBuy7K$0.21$1K37K
2023-08-25LEE WILLIS CCOOBuy1K$0.21$28737K
2023-08-25Lim Seah H.DirectorBuy92K$0.27$25K156K
2023-05-31LEE WILLIS CCOOBuy29K$0.29$8K31K
2022-11-30Niihara YutakaChairman and CEOBuy23K$0.41$9K12.0M
2022-11-29Niihara YutakaChairman and CEOBuy15K$0.38$6K12.0M
2022-11-28Niihara YutakaChairman and CEOBuy5K$0.35$2K12.0M
2022-11-04Niihara YutakaChairman and CEOBuy8K$0.45$3K12.0M
2022-11-03Niihara YutakaChairman and CEOBuy3K$0.45$1K12.0M
2022-11-02Niihara YutakaChairman and CEOBuy15K$0.43$6K12.0M
2022-11-01Niihara YutakaChairman and CEOBuy5K$0.43$2K12.0M
2022-10-31Niihara YutakaChairman and CEOBuy8K$0.45$3K12.0M
2022-10-28Niihara YutakaChairman and CEOBuy8K$0.42$3K12.0M
2022-10-27Niihara YutakaChairman and CEOBuy23K$0.27$6K12.0M
2022-10-26Niihara YutakaChairman and CEOBuy12K$0.27$3K11.9M
2022-10-25Niihara YutakaChairman and CEOBuy20K$0.26$5K11.9M
2022-10-24Niihara YutakaChairman and CEOBuy8K$0.22$2K11.9M
2022-10-21Niihara YutakaChairman and CEOBuy10K$0.19$2K11.9M
2022-10-20Niihara YutakaChairman and CEOBuy30K$0.18$5K11.9M
2022-10-19Niihara YutakaChairman and CEOBuy25K$0.16$4K11.9M
2022-10-18Niihara YutakaChairman and CEOBuy30K$0.19$6K11.8M
2022-10-17Niihara YutakaChairman and CEOBuy15K$0.20$3K11.8M
2022-10-14Niihara YutakaChairman and CEOBuy35K$0.17$6K11.8M
2022-10-13Niihara YutakaChairman and CEOBuy63K$0.18$11K11.7M
2022-10-12Niihara YutakaChairman and CEOBuy160K$0.08$13K11.7M
2022-10-11Niihara YutakaChairman and CEOBuy130K$0.09$12K11.5M
2022-10-11Niihara YutakaChairman and CEOBuy5K$0.09$45011.5M
2022-10-10Niihara YutakaChairman and CEOBuy10K$0.09$90011.4M
2022-10-09Lim Seah H.DirectorBuy25K$0.11$3K64K
2022-10-07Niihara YutakaChairman and CEOBuy4K$0.13$52011.4M
2022-10-06Niihara YutakaChairman and CEOBuy5K$0.15$75011.4M
2022-10-05Niihara YutakaChairman and CEOBuy10K$0.15$2K11.4M
2022-10-04Niihara YutakaChairman and CEOBuy5K$0.16$80011.4M
2022-10-03Niihara YutakaChairman and CEOBuy10K$0.20$2K11.4M
2022-09-27Niihara YutakaChairman and CEOBuy5K$0.20$1K11.3M
2022-09-26Niihara YutakaChairman and CEOBuy6K$0.20$1K11.3M
2022-09-20LEE WILLIS CCOOBuy750$0.28$210288K
2022-07-19LEE WILLIS CCOOBuy3K$0.39$1K287K
2022-05-31LEE WILLIS CDirector & COOBuy3K$0.40$1K284K
2022-05-27LEE WILLIS CDirector & COOBuy3K$0.37$925281K
2022-05-23Niihara YutakaChairman and CEOBuy2K$0.50$1K11.3M
2022-05-20Niihara YutakaChairman and CEOBuy5K$0.49$2K11.3M
2022-05-18Niihara YutakaChairman and CEOBuy7K$0.35$3K11.3M
2022-05-13Niihara YutakaChairman and CEOBuy10K$0.34$3K11.3M
2022-05-09Niihara YutakaChairman and CEOBuy6K$0.60$4K11.3M
2022-04-11LEE WILLIS CDirector & COOBuy9K$0.88$8K279K
2022-04-08LEE WILLIS CDirector & COOBuy2K$0.76$1K241K
2022-04-06LEE WILLIS CDirector & COOBuy1K$0.95$1K240K
2022-04-04LEE WILLIS CDirector & COOBuy3K$0.98$3K238K
2022-02-28LEE WILLIS CVice Chairman & COOBuy7K$1.51$11K270K
2022-02-28LEE WILLIS CVice Chairman & COOBuy7K$1.50$10K235K
2022-02-28LEE WILLIS CVice Chairman & COOBuy900$1.65$1K2K
2022-02-28Niihara YutakaChairman and CEOBuy54K$1.49$80K11.3M
2022-02-25Niihara YutakaChairman and CEOBuy6K$1.41$8K11.2M
2022-02-24Niihara YutakaChairman and CEOBuy11K$1.43$16K11.2M
2022-02-24LEE WILLIS CVice Chairman & COOBuy6K$1.44$8K263K
2022-02-22Niihara YutakaChairman and CEOBuy18K$1.44$26K11.2M
2022-02-22LEE WILLIS CVice Chairman & COOBuy500$1.42$710257K
2022-02-18Niihara YutakaChairman and CEOBuy2K$1.43$2K11.2M
2022-02-17Niihara YutakaChairman and CEOBuy7K$1.43$9K11.2M
2022-02-16Niihara YutakaChairman and CEOBuy1K$1.47$1K11.2M
2022-02-15Niihara YutakaChairman and CEOBuy6K$1.45$9K11.2M
2022-02-14Niihara YutakaChairman and CEOBuy6K$1.45$9K11.2M
2022-02-11Niihara YutakaChairman and CEOBuy4K$1.49$6K11.2M
2022-02-10Niihara YutakaChairman and CEOBuy3K$1.45$4K11.2M
2022-02-09Niihara YutakaChairman and CEOBuy24K$1.45$34K11.2M
2022-02-08Niihara YutakaChairman and CEOBuy3K$1.49$5K11.2M
2022-02-07Niihara YutakaChairman and CEOBuy5K$1.47$8K11.2M
2022-02-04Niihara YutakaChairman and CEOBuy7K$1.43$10K11.2M
2022-02-03Niihara YutakaChairman and CEOBuy6K$1.40$9K11.1M
2022-01-03Lui Alfred Fu KongDirectorBuy10K$1.58$16K10K
2021-12-31Niihara YutakaChairman and CEOBuy7K$1.58$11K11.1M
2021-12-30Niihara YutakaChairman and CEOBuy7K$1.56$11K11.1M

Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are rarer.

What this page is

Emmaus Life Sciences in the regulatory record

Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page puts those series for one ticker on one URL, with planned sales, large holders, 13F holders and financials beside them, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.

Each section has its own history table, a one-line summary of the latest figures and its own JSON and CSV links, and says when its source last updated.

This page follows Emmaus Life Sciences (EMMA), SEC CIK 822370, listed on OTC, classified by the SEC as pharmaceutical preparations. The cross-market tables live on the short interest and insider transactions hubs.

Source and updates

Short interest
FINRA consolidated short interestSource: FINRA.Twice a month, about eight business days after settlement. Latest 2026-10-15.JSON and CSV
Fails to deliver
SEC fails-to-deliver dataSource: SEC.Twice a month, a few weeks after the half month ends. Latest 2026-09-01.JSON and CSV
Earnings dates
SEC EDGAR 8-K filings (Item 2.02)Source: SEC.Twice a day. Reported dates come from the company's 8-K filings; the next date is marked as an estimate until the 8-K arrives. Latest 2026-08-14.JSON and CSV
Insider trades
SEC EDGAR Form 4Source: SEC.New filings appear shortly after the SEC posts them; they're due two business days after the trade. Latest 2026-08-31.JSON and CSV
Company record
EDGAR filing index for CIK 822370Ticker, name and exchange from the SEC's company list, refreshed weekly.
Rate limits
10 requests a minute without a key, 30 with a free key from a free account.

How to read it

  • Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
  • Insider buys next to a large short position are rare and stand out; insider sells next to one are common and mean little.
  • Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.

Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.

Other companies the SEC classifies as pharmaceutical preparations

Other company pages

Datasets

Frequently Asked Questions

How much of EMMA is sold short?
3,004 shares were held short at the 2026-10-15 settlement, 1.0 days of average volume. FINRA publishes the next count about eight business days after the 15th and the last business day of the month.
What is EMMA's daily short volume?
No daily short volume file lists EMMA yet.
Does EMMA have fails to deliver?
The SEC's latest file shows 4,583 EMMA shares failed to deliver at settlement 2026-09-01. Fails are reported per settlement date and published twice a month with a lag.
Are EMMA insiders buying or selling?
Insiders at EMMA reported 4 open-market buys worth $15K in the last 90 days and no open-market sells. Latest filing: LEE WILLIS C (CEO) on 2026-08-31.

Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.